Compare FGBI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FGBI | CBUS |
|---|---|---|
| Founded | 1934 | 2010 |
| Country | United States | United States |
| Employees | 339 | N/A |
| Industry | Savings Institutions | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 208.7M |
| IPO Year | N/A | 2017 |
| Metric | FGBI | CBUS |
|---|---|---|
| Price | $8.59 | $3.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 9.4K | ★ 525.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | N/A | ★ 58.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,262,000.00 |
| Revenue This Year | $567.70 | N/A |
| Revenue Next Year | N/A | $99.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 134.56 |
| 52 Week Low | $4.31 | $1.09 |
| 52 Week High | $10.55 | $3.80 |
| Indicator | FGBI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 69.44 |
| Support Level | $7.79 | $1.34 |
| Resistance Level | $8.72 | N/A |
| Average True Range (ATR) | 0.21 | 0.31 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 36.61 | 85.11 |
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.